🏠
Menarini Glucocard G+
Device Name:
Glucocard G+
Manufacturer:

OBL: A. Menarini Diagnostics S.r.l., Via Sette Santi 3, 50131 Firenze, ITALY.

OEM: Arkray Global Business Inc., 1408 Koji, Konan cho, koka shi, Shiga, JAPAN.

Measuring functions:
Blood glucose
Primary Client Use:
Intended for self-measurement and home use
Measurement Site:
Finger
Measurement Occurrence:
Single measurements only
Availability:
Available Currently
Device Manual:
Description:
The Menarini Glucocard G+ is an automatic blood glucose meter. Its blood glucose measurement technology has been proven to be accurate, with a 2-star Medaval rating. Blood glucose measurements are taken from the finger. It is intended for self-measurement and home use.
Assessment:
The technology used in the Menarini Glucocard G+, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
Recommendations:
Accuracy AssessmentRecommendationBasis
BG Medaval ★★ Recommendation Recent clinical validation; recent protocol
BG MDR Criteria Self-measurement Published evidence
Validation Publications:

Pfützner A, Schipper C, Ramljak S, Flacke F, Sieber J, Forst T, Musholt PB. Evaluation of the effects of insufficient blood volume samples on the performance of blood glucose self-test meters. J Diabetes Sci Technol. 2013 Nov 1;7(6):1522-9. doi: 10.1177/193229681300700612. PMID: 24351178. Available from: PMC3876330.

15197:2003 - Fail Using insufficient blood samples (n=31)

Berti F, Scuffi C, Valgimigli F. Accuracy Evaluation of Two Blood Glucose Monitoring Systems Following ISO 15197:2013. J Diabetes Sci Technol. 2015 Nov;9(6):1354-6. Epub: 2015 Jul 29. doi: 10.1177/1932296815595986. PMID: 26224761. No abstract available.

15197:2013 - Pass General population

Mancini A, Esposto G, Manfrini S, Rilli S, Tinti G, Carta G, Petrolati L, Vidali M, Barocci S. A Real-World Setting Study: Which Glucose Meter Could Be the Best for POCT Use? An Easy and Applicable Protocol During the Hospital Routine. J Diabetes Sci Technol. 2018 Sep;12(5):1053-1060. Epub: 2018 May 22. doi: 10.1177/1932296818774077. PMID: 29783898. Available from: PMC6134620.

SIBioC:2015 General population

Note: Results from this paper are not presented due to a number of inaccuracies. One of these refers to the "Glucocard G-sensor" being presented as a device whereas these are test strips for the "Glucocard G" and "Glucocard G+" devices.

Relevant Publications:

Musholt PB, Schipper C, Thomé N, Ramljak S, Schmidt M, Forst T, Pfützner A. Dynamic electrochemistry corrects for hematocrit interference on blood glucose determinations with patient self-measurement devices. J Diabetes Sci Technol. 2011 Sep 1;5(5):1167-75. doi: 10.1177/193229681100500520. PMID: 22027312. Available from: PMC3208875.

Reliable correction for potential haematocrit influence.